Companies: 10,795·Total market cap: $144.5T
Medite Cancer Diagnostics, Inc.

Medite Cancer Diagnostics, Inc.

MDITOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$8672
P/E Ratio—
52W High$0.005
52W Low$0.0001
Overview
股票排行：Medical - Instruments & Supplies·Healthcare·查看全部市值排行 →

Medite Cancer Diagnostics, Inc.（MDIT）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · MDIT · 截至 Jun 8, 2026

关键指标

EPS (TTM)—mdit eps ttm · mdit earnings per shareEarnings history
PE Ratio (TTM)—mdit pe ratio ttm · mdit price to earningsPE Ratio deep dive
Revenue (TTM)—mdit revenue ttm · mdit annual revenueFull revenue history
Dividend Yield不分红does mdit pay dividends · mdit dividend yieldDividend history
Shares Outstanding26.4Mmdit shares outstanding · mdit floatShares outstanding history
Next EarningsTBAmdit earnings date · mdit next earningsEarnings history

探索 Medite Cancer Diagnostics, Inc. 数据

mdit stock data · financials
市值$8,672mdit market cap · mdit valuation
分析师预测—
股息不分红does medite cancer diagnostics, inc. pay dividends · mdit dividend yield
营收$6.8M-26.25%medite cancer diagnostics, inc. annual revenue · mdit revenue
盈利EPS $-0.26-160.00%mdit earnings · mdit eps
市盈率—mdit pe ratio · mdit price to earnings

财务快照

完整财报
FY 2017Revenue$6.8M▼ 26.25% YoY
201520162017
medite cancer diagnostics, inc. revenue · mdit revenue 2017
FY 2017Net Income-$6.8M▼ 214.89% YoY
201520162017
medite cancer diagnostics, inc. net income · mdit profit 2017
FY 2017EPS$-0.26▼ 160.00% YoY
201520162017
mdit eps · medite cancer diagnostics, inc. earnings per share 2017
TTM:View income statement →

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y+0.00%
5Y-99.44%

关于 Medite Cancer Diagnostics, Inc.

CEOJeffrey Rencher
IPO DateFeb 2, 1995
Employees69
CountryUS
Websitemedite-group.com

Medite Cancer Diagnostics, Inc. functions as a specialized medical technology enterprise focused on the development, manufacturing, and commercialization of molecular biomarkers, sophisticated medical…

Medical - Instruments & SuppliesHealthcareOTCUS

what is medite cancer diagnostics, inc. · mdit stock overview · medite cancer diagnostics, inc. company profile · who is medite cancer diagnostics, inc. ceo · mdit OTC · medite cancer diagnostics, inc. headquarters · medite cancer diagnostics, inc. business segments

关于股票概览与关键数据

Medite Cancer Diagnostics, Inc.（MDIT）是 Medical - Instruments & Supplies 行业的 Healthcare 类公司，于 Feb 2, 1995 在 OTC 上市。截至最近交易日，MDIT 股价为 $0.00，市值约为 $8,672。过去12个月累计回报 +0.00%，年初至今回报 +0.00%。

2017 财年 Medite Cancer Diagnostics, Inc. 营收 $6.8M。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Medite Cancer Diagnostics, Inc.（MDIT）股价为 $0.00，在 OTC 上市，52周区间为 $0.00 – $0.01。

MDIT 最新股价MDIT quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议